STAR

STRIDES PHARMA SCIENCE

Small Cap BSE: 532531 NSE: STAR
₹347.6
-1.65 (-0.47%)
As on 16 August, 2022 | 20:47

Strides Pharma Science Share Price

Strides Pharma Science Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Strides Pharma Science Share Returns

  • Over 1 Month 2.24%
  • Over 3 Month 17.39%
  • Over 6 Month -7.27%
  • Over 1 Year -45.18%

Strides Pharma Science Key Statistics

P/E Ratio -8
PEG Ratio 0
Market Cap Cr 3,122
Price to Book Ratio 1.3
EPS 20.1
Dividend 0
Relative Strength Index 55.5
Money Flow Index 67.46
MACD Signal 3.09
Average True Range 11.26

Strides Pharma Science Investment Rating

  • Master Rating:
  • Strides Pharma Science has an operating revenue of Rs. 3,321.96 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of -18% needs improvement, ROE of -19% is poor and needs improvement. The company has a reasonable debt to equity of 35%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 5% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 27 which is a POOR score indicating inconsistency in earnings, a RS Rating of 29 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 96 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Strides Pharma Science Financials
  • Indicator
  • Jun 2022
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev Qtr Cr
  • 423
  • 456
  • 440
  • 575
  • 509
  • 634
  • Operating Expenses Qtr Cr
  • 484
  • 438
  • 436
  • 528
  • 501
  • 546
  • Operating Profit Qtr Cr
  • -61
  • 18
  • 4
  • 47
  • 8
  • 88
  • Depreciation Qtr Cr
  • 24
  • 24
  • 26
  • 27
  • 27
  • 25
  • Interest Qtr Cr
  • 26
  • 22
  • 17
  • 18
  • 18
  • 18
  • Tax Qtr Cr
  • -38
  • -144
  • -14
  • 6
  • -7
  • 21
  • Net Profit Qtr Cr
  • -66
  • 201
  • -18
  • 19
  • -21
  • 48

Strides Pharma Science Technicals

EMA & SMA

Current Price
347.6
-1.65 (-0.47%)
  • Bullish Moving Average
  • ___
  • 14
  • Bearish Moving Average
  • ___
  • 2
  • 20 Day
  • 342.21
  • 50 Day
  • 336.94
  • 100 Day
  • 346.14
  • 200 Day
  • 381.14
  • 20 Day
  • 341.93
  • 50 Day
  • 333.03
  • 100 Day
  • 332
  • 200 Day
  • 380.52

Strides Pharma Science Resistance and Support

PIVOT
₹348.42
Resistance
  • First Resistance
  • 354.54
  • Second Resistance
  • 359.82
  • Third Resistance
  • 365.94
Support
  • First Resistance
  • 343.14
  • Second Resistance
  • 337.02
  • Third Resistance
  • 331.74
  • RSI
  • 55.5
  • MFI
  • 67.46
  • MACD Single Line
  • 3.09
  • MACD
  • 3.34

Strides Pharma Science Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 274,715
  • 9,142,515
  • 33.28
  • Week
  • 380,392
  • 11,754,105
  • 30.9
  • 1 Month
  • 409,942
  • 11,986,695
  • 29.24
  • 6 Month
  • 950,613
  • 24,487,801
  • 25.76

Strides Pharma Science Result Highlights

Strides Pharma Science Synopsis

NSE-Medical-Generic Drugs

Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1857.57 Cr. and Equity Capital is Rs. 89.68 Cr. for the Year ended 31/03/2021. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.
  • Market Cap
  • 3,119
  • Sales
  • 1,893
  • Shares in Float
  • 6.29
  • No of funds
  • 136
  • Yield
  • 0.36
  • Book Value
  • 0.92
  • U/D Vol ratio
  • 1.2
  • LTDebt / Equity
  • 4
  • Alpha
  • -0.25
  • Beta
  • 1.42

Strides Pharma Science

  • Owner Name
  • Jun-22
  • Mar-22
  • Dec-21
  • Sep-21
  • Promoters
  • 30.37%
  • 30.6%
  • 29.6%
  • Mutual Funds
  • 9.81%
  • 12.39%
  • 14.84%
  • Foreign Portfolio Investors
  • 21.21%
  • 19.66%
  • 19.85%
  • Financial Institutions/ Banks
  • 0.01%
  • 0.01%
  • 0.01%
  • Individual Investors
  • 22.29%
  • 21.82%
  • 20.42%
  • Others
  • 16.31%
  • 15.52%
  • 15.28%

Strides Pharma Science Management

  • Name
  • Designation
  • Mr. Arun Kumar
  • Chairman & Non-Exe.Director
  • Dr. R Ananthanarayanan
  • Managing Director & CEO
  • Mr. Badree Komandur
  • Executive Director & Group CFO
  • Mr. Deepak Vaidya
  • Non Executive Director
  • Dr. Kausalya Santhanam
  • Independent Director
  • Mr. Bharat D Shah
  • Independent Director
  • Mr. Homi Rustam Khusrokhan
  • Independent Director
  • Mr. S Sridhar
  • Independent Director

Strides Pharma Science Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Strides Pharma Science Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-07-29
  • Quarterly Results
  • 2022-07-25
  • Others
  • Inter alia, to consider and approve Intimation of raising of funds by way of issuance of Non-Convertible Debentures under Regulation 29 of SEBI Listing Regulations. per share(45%)Dividend
  • 2022-05-24
  • Audited Results & Dividend
  • 2022-02-10
  • Quarterly Results & Others
  • To consider Fund Raising (Revised) per share(45%)Dividend
  • 2021-11-10
  • Quarterly Results
  • Date
  • Purpose
  • Remarks
  • 2021-08-06
  • FINAL
  • Rs.2.50 per share(25%)Final Dividend

Strides Pharma Science MF Shareholding

  • Name
  • Amount(cr)
  • Kotak Equity Arbitrage Fund Growth
  • 24543
  • Aditya Birla Sun Life Flexi Cap Fund Growth
  • 15652
  • ICICI Prudential Equity Arbitrage Fund Regular Growth
  • 12574
  • SBI Magnum Long Term Equity Scheme Regular Payout of Income Distribution cum capital wdrl
  • 10746
  • Nippon India Arbitrage Fund Growth
  • 10295

Strides Pharma Science FAQs

What is Share Price of Strides Pharma Science ?

Strides Pharma Science share price is ₹347 As on 16 August, 2022 | 20:33

What is the Market Cap of Strides Pharma Science ?

The Market Cap of Strides Pharma Science is ₹3121.6 Cr As on 16 August, 2022 | 20:33

What is the P/E ratio of Strides Pharma Science ?

The P/E ratio of Strides Pharma Science is -8 As on 16 August, 2022 | 20:33

What is the PB ratio of Strides Pharma Science ?

The PB ratio of Strides Pharma Science is 1.3 As on 16 August, 2022 | 20:33

Q1FY23